NCT06406569Completed
A Qualitative and Usability Evaluation of Advanced Technologies for Home Upper Limb Neurorehabilitation Post-stroke
Home RehabGym: a Qualitative and Usability Evaluation of Advanced Technologies for Home Upper Limb Neurorehabilitation Post-stroke
Source: ClinicalTrials.gov · Last updated 7 Oct 2026
Brief summary (registry, in English)
Due to limited resources such as the low therapist to patient ratio or high costs associated to rehabilitation therapy, providing higher therapy dose to patients after discharge is highly challenging. This often results in non-use of the impaired limb as a result of the decreased therapy dose, causing partial loss of the functional improvements previously gained during early rehabilitation. In this study, the investigators plan to pilot the HomeRehab Gym concept via the deployment of three rehabilitation devices at patients' homes: MyoPanda, H-Man and ReHandyBot.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 29 (actual)
- First submitted
- 6 May 2024
- Start date
- 31 Jul 2024
- Primary completion date
- 5 Jun 2026
- Lead sponsor
- Tan Tock Seng Hospital
- Diseases
- Stroke
- NCT number
- NCT06406569
What you commit to
- Study type: Interventional
- Participants enrolled: 29
- From 31 Jul 2024 to the primary completion date, 5 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Pacemakers and other active implants
- Local factors potentially worsened by intensive technology-aided upper-limb therapy and computer-based training:
- Spasticity - modified Ashworth Scale MAS \> 2 of any upper limb muscle groups
- Severe pain in affected arm - Visual Analogue Scale for pain VAS \> 5/10
- Skin wounds
Other illness
- Functional impairment of the upper limb due to other pathologies
- Medical conditions incompatible with research participation: uncontrolled medical illnesses (hypertension or diabetes, ischaemic heart disease, congestive heart failure, bronchial asthma, severe /untreated depression, agitation, end stage renal/liver/heart/lung failure, unresolved cancers)
- Active seizures within 3 months
- Cognitive impairment precluding study participation
- Severe visual impairment or visual neglect affecting ability to use technologies
- History of dementia, depression or behavioural problems
Other
- Anticipated life expectancy of less than 6 months
- Pregnant or lactating females will not be allowed to participate
Who the study is looking for
- Clinical stroke (ischaemic or haemorrhagic) confirmed by admitting doctors and CT, CT angiography or MRI brain imaging
- Age 21 to 80 years, both males and females
- At least 28 days post-stroke
- Upper limb motor impairment of Fugl-Meyer Assessment (FMA) scale 20 to 50
- Montreal Cognitive Assessment (MoCA) \> 21/30
- Ability to sit supported and continuously for 60 minutes
- Stable home abode with enough space to place technologies
- Has a carer/next of kin to supervise home-based exercises
Age in the registry: 21 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tan Tock Seng Hospital Coordinator of this site? Confirm its status | Singapore | Singapore | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.